USX:ONVO - Organovo Holdings Inc (USD 0.318) Organovo Holdings Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 0.3182    -0.011 (-3.40%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: -0.011 (-3.40%)

52 Wk Range: 0.1933 - 1.05

Day's Range: 0.2901 - 0.33

Last Volume: 689,398

Current Yield: 0%

Projected Yield: 0%

Open: USD 0.3262

9 Apr 2020

Metric ONVO S.Median
Beta 1.16 0.84
VaR 69.08 25.23
E.Shortfall 126.17 45.03
Liquidity 417.04K 95.2K


9 Apr 2020

PE: -1.541

Market Cap: 40.1M

Price Over Book: 1.289

Price Over Sales: 11.93

Return On Assets: -68.8%

Return On Equity: -83.7%

Price Over NAV: [Friends Only]


CEO: Taylor J. Crouch

Headquarters: SAN DIEGO

Employees: 61

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. It is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease for use in drug discovery and development; and three-dimensional human tissues for clinical applications, such as blood vessels for bypass grafting, nerve grafts for nerve damage repair, and functional tissue patches for the repair or replacement of damaged tissues and organs. The company has collaboration agreements with L'Oreal USA and Merck & Co. Organovo Holdings, Inc. was founded in 2007 and is headquartered in San Diego, California.